Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Gene: RGD1565367 (similar to Solute carrier family 23, member 2 (Sodium-dependent vitamin C transporter 2)) Rattus norvegicus
Analyze
Symbol: RGD1565367
Name: similar to Solute carrier family 23, member 2 (Sodium-dependent vitamin C transporter 2)
Description: Predicted to have transmembrane transporter activity. Predicted to be involved in transmembrane transport. Predicted to localize to the integral component of membrane; INTERACTS WITH acrylamide; copper atom; copper(0).
Type: protein-coding
RefSeq Status: PROVISIONAL
Also known as: LOC312226; similar to Solute carrier family 23, member 2 (Sodium-dependent vitamin C transporter 2) (mSVCT2) (Na+/L-ascorbic acid transporter 2) (Yolk sac permease-like molecule 2); slc23A4; SNBT1; sodium-dependent nucleobase transporter 1; solute carrier family 23 member 2-like
Orthologs:
No known orthologs. homologs ...
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rnor_6.0462,480,058 - 62,526,724 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.0462,208,285 - 62,262,195 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.4462,337,411 - 62,401,000 (-)NCBIRGSC3.4rn4RGSC3.4
Celera458,682,468 - 58,729,396 (-)NCBICelera
Cytogenetic Map4q22NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene-Chemical Interaction Annotations
Gene Ontology Annotations
References - curated
References - uncurated

Genomics

QTLs in Region (Rnor_6.0)
miRNA Target Status

Sequence

Nucleotide Sequences
Protein Sequences
Transcriptome
Promoters

Strain Variation

Strain Sequence Variants (Rnor 5.0)

Additional Information

External Database Links
Nomenclature History
 
More on RGD1565367
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

RGD Object Information
RGD ID: 1565367
Created: 2006-02-09
Species: Rattus norvegicus
Last Modified: 2019-07-09
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.